AI-based differential diagnosis of dementia etiologies on multimodal data

Chonghua Xue,Sahana S. Kowshik,Diala Lteif,Shreyas Puducheri,Varuna H. Jasodanand,Olivia T. Zhou,Anika S. Walia,Osman B. Guney,J. Diana Zhang,Serena T. Pham,Artem Kaliaev,V. Carlota Andreu-Arasa,Brigid C. Dwyer,Chad W. Farris,Honglin Hao,Sachin Kedar,Asim Z. Mian,Daniel L. Murman,Sarah A. O’Shea,Aaron B. Paul,Saurabh Rohatgi,Marie-Helene Saint-Hilaire,Emmett A. Sartor,Bindu N. Setty,Juan E. Small,Arun Swaminathan,Olga Taraschenko,Jing Yuan,Yan Zhou,Shuhan Zhu,Cody Karjadi,Ting Fang Alvin Ang,Sarah A. Bargal,Bryan A. Plummer,Kathleen L. Poston,Meysam Ahangaran,Rhoda Au,Vijaya B. Kolachalama

DOI: https://doi.org/10.1101/2024.02.08.24302531

2024-03-26

Abstract:Differential diagnosis of dementia remains a challenge in neurology due to symptom overlap across etiologies, yet it is crucial for formulating early, personalized management strategies. Here, we present an AI model that harnesses a broad array of data, including demographics, individual and family medical history, medication use, neuropsychological assessments, functional evaluations, and multimodal neuroimaging, to identify the etiologies contributing to dementia in individuals. The study, drawing on 51, 269 participants across 9 independent, geographically diverse datasets, facilitated the identification of 10 distinct dementia etiologies. It aligns diagnoses with similar management strategies, ensuring robust predictions even with incomplete data. Our model achieved a micro-averaged area under the receiver operating characteristic curve (AUROC) of 0.94 in classifying individuals with normal cognition, mild cognitive impairment and dementia. Also, the micro-averaged AUROC was 0.96 in differentiating the dementia etiologies. Our model demonstrated proficiency in addressing mixed dementia cases, with a mean AUROC of 0.78 for two cooccurring pathologies. In a randomly selected subset of 100 cases, the AUROC of neurologist assessments augmented by our AI model exceeded neurologist-only evaluations by 26.25%. Furthermore, our model predictions aligned with biomarker evidence and its associations with different proteinopathies were substantiated through postmortem findings. Our framework has the potential to be integrated as a screening tool for dementia in various clinical settings and drug trials, with promising implications for person-level management.

Neurology

What problem does this paper attempt to address?

The paper attempts to address the challenge of differential diagnosis of dementia. Specifically, the symptoms exhibited by various causes of dementia overlap clinically, making it difficult to formulate early, personalized management strategies. Therefore, the authors propose a multimodal data model based on artificial intelligence (AI) aimed at identifying the specific causes of dementia in individuals by integrating multiple data sources such as demographic information, personal and family medical history, medication usage, neuropsychological assessments, functional evaluations, and multimodal neuroimaging. ### Main Issues: 1. **Symptom Overlap**: Different causes of dementia have overlapping clinical presentations, making accurate diagnosis difficult. 2. **Personalized Management**: Early, personalized management strategies are needed to improve patient treatment outcomes and quality of life. 3. **Incomplete Data**: In real clinical scenarios, data is often incomplete, requiring a model that can handle incomplete data. 4. **Multiple Etiologies**: Many patients may have multiple types of dementia simultaneously, necessitating a model that can handle mixed etiologies. ### Solution: - **Multimodal Data Integration**: Utilizing multiple data sources such as demographics, medical history, medication usage, neuropsychological assessments, functional evaluations, and multimodal neuroimaging. - **AI Model**: Developed an AI model capable of handling the aforementioned multimodal data to improve diagnostic accuracy and efficiency. - **Robustness**: The model maintains high diagnostic accuracy even with incomplete data. - **Mixed Etiology Identification**: The model can identify and distinguish cases with multiple coexisting etiologies, providing the probability for each cause. ### Main Results: - **High Accuracy**: The model achieved a micro-average Area Under the Receiver Operating Characteristic (AUROC) of 0.94 in classifying normal cognition, mild cognitive impairment, and dementia. - **Etiology Identification**: Achieved a micro-average AUROC of 0.96 in distinguishing different types of dementia. - **Mixed Cases**: For cases with two or more coexisting etiologies, the model's average AUROC reached 0.78. - **Clinical Application**: Compared to neurologists' diagnoses, the AI-enhanced diagnostic accuracy improved by 26.25%. - **Biomarker Validation**: The probabilities predicted by the model were consistent with biomarker detection results, further validating the model's effectiveness. - **Pathological Validation**: The probabilities predicted by the model were consistent with post-mortem pathological examination results, further proving the model's accuracy. In summary, this paper successfully addresses several key issues in the differential diagnosis of dementia by developing a multimodal AI model, providing strong support for clinical practice.

AI-based differential diagnosis of dementia etiologies on multimodal data

Develop a Diagnostic Tool for Dementia Using Machine Learning and Non-Imaging Features

Multimodal deep learning for Alzheimer’s disease dementia assessment

Visual deep learning of unprocessed neuroimaging characterises dementia subtypes and generalises across non-stereotypic samples

Data-driven discovery of probable Alzheimer's disease and related dementia subphenotypes using electronic health records

Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review

Precise Discrimination for Multiple Etiologies of Dementia Cases Based on Deep Learning with Electroencephalography

Prediction of future dementia among patients with mild cognitive impairment (MCI) by integrating multimodal clinical data

Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease

Cascaded Multimodal Deep Learning in the Differential Diagnosis, Progression Prediction, and Staging of Alzheimer's and Frontotemporal Dementia

Multi-Modal Data Analysis for Alzheimer’s Disease Diagnosis: An Ensemble Model Using Imagery and Genetic Features

Predicting changes in brain metabolism and progression from mild cognitive impairment to dementia using multitask Deep Learning models and explainable AI

A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer’s disease

Development and validation of a deep learning framework for Alzheimer’s disease classification

Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA

A Multi-Modal Classification Method for Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease Using Three Paradigms With Various Task Difficulties

CHARACTERIZING STRUCTURAL BRAIN ALTERATIONS IN ALZHEIMER’S DISEASE PATIENTS WITH MACHINE LEARNING

Integrating Demographics and Imaging Features for Various Stages of Dementia Classification: Feed Forward Neural Network Multi-Class Approach

Development and validation of an interpretable deep learning framework for Alzheimer's disease classification

Interpretable differential diagnosis for Alzheimer's disease and Frontotemporal dementia

Multi-view Ensemble Learning for Dementia Diagnosis from Neuroimaging: an Artificial Neural Network Approach